Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5994)
All Articles published online
|
Feb 14, 2013 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Koutsounas I, Giaginis C, Patsouris E, Theocharis S. Current evidence for histone deacetylase inhibitors in pancreatic cancer. World J Gastroenterol 2013; 19(6): 813-828 [PMID: 23430136 DOI: 10.3748/wjg.v19.i6.813] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i6/813.htm |
| Number | Citing Articles |
| 1 |
Fouad Choueiry, Molly Torok, Reena Shakya, Kriti Agrawal, Anna Deems, Brooke Benner, Alice Hinton, Jami Shaffer, Bradley W Blaser, Anne M Noonan, Terence M Williams, Mary Dillhoff, Darwin L Conwell, Phil A Hart, Zobeida Cruz-Monserrate, Xue-Feng Bai, William E Carson III, Thomas A Mace. CD200 promotes immunosuppression in the pancreatic tumor microenvironment. Journal for ImmunoTherapy of Cancer 2020; 8(1): e000189 doi: 10.1136/jitc-2019-000189
|
| 2 |
Hua Zhang, Xufeng Dai, Yan Qi, Ying He, Wei Du, Ji-jing Pang. Histone Deacetylases Inhibitors in the Treatment of Retinal Degenerative Diseases: Overview and Perspectives. Journal of Ophthalmology 2015; 2015: 1 doi: 10.1155/2015/250812
|
| 3 |
Jingjing Gong, Amanda R. Muñoz, Daniel Chan, Rita Ghosh, Addanki P. Kumar. STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth. Oncotarget 2014; 5(9): 2529 doi: 10.18632/oncotarget.1810
|
| 4 |
Dinesh Kumar, Pranjal Sarma, Manika P. Bhadra, Anjana D. Tangutur. Impact of Hybrid-polar Histone Deacetylase Inhibitor m-Carboxycinnamic Acid bis-Hydroxyamide on Human Pancreatic Adenocarcinoma Cells. Anti-Cancer Agents in Medicinal Chemistry 2019; 19(6): 750 doi: 10.2174/1871520619666190101115034
|
| 5 |
Ei Nakajima, Kouhei Shimaji, Takanari Umegawachi, Saki Tomida, Hideki Yoshida, Nana Yoshimoto, Shingo Izawa, Hiroshi Kimura, Masamitsu Yamaguchi, Efthimios M. C. Skoulakis. The Histone Deacetylase Gene Rpd3 Is Required for Starvation Stress Resistance. PLOS ONE 2016; 11(12): e0167554 doi: 10.1371/journal.pone.0167554
|
| 6 |
Richard S. Laschanzky, Lisa E. Humphrey, Jihyun Ma, Lynette M. Smith, Thomas J. Enke, Surendra K. Shukla, Aneesha Dasgupta, Pankaj K. Singh, Gillian M. Howell, Michael G. Brattain, Quan P. Ly, Adrian R. Black, Jennifer D. Black. Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy. Cancers 2019; 11(9): 1327 doi: 10.3390/cancers11091327
|
| 7 |
Maïté Rielland, David J. Cantor, Richard Graveline, Cristina Hajdu, Lisa Mara, Beatriz de Diego Diaz, George Miller, Gregory David. Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression. Journal of Clinical Investigation 2014; 124(5): 2125 doi: 10.1172/JCI72619
|
| 8 |
Zhao-Chun Chi. Research status and prgoress of nonalcoholic fatty pancreatic disease. World Chinese Journal of Digestology 2020; 28(19): 933 doi: 10.11569/wcjd.v28.i19.933
|
| 9 |
Wan Feng, Bin Zhang, Dawei Cai, Xiaoping Zou. Therapeutic potential of histone deacetylase inhibitors in pancreatic cancer. Cancer Letters 2014; 347(2): 183 doi: 10.1016/j.canlet.2014.02.012
|
| 10 |
Yusuke Kojima, Reeja S. Maskey, Yuichi J. Machida. Pancreatic Cancer. 2017; : 1 doi: 10.1007/978-1-4939-6631-8_74-1
|
| 11 |
Henry F. Duncan, Anthony J. Smith, Garry J. P. Fleming, Nicola C. Partridge, Emi Shimizu, Gary P. Moran, Paul R. Cooper. The Histone‐Deacetylase‐Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase‐13 Activity. Journal of Cellular Physiology 2016; 231(4): 798 doi: 10.1002/jcp.25128
|
| 12 |
Nianhong Chen, Qiaoqiao Zheng, Guoqing Wan, Feng Guo, Xiaobin Zeng, Ping Shi. Impact of posttranslational modifications in pancreatic carcinogenesis and treatments. Cancer and Metastasis Reviews 2021; 40(3): 739 doi: 10.1007/s10555-021-09980-4
|
| 13 |
Constantinos Giaginis, Christos Damaskos, Ioannis Koutsounas, Adamantia Zizi-Serbetzoglou, Nicolaos Tsoukalas, Efstratios Patsouris, Gregorios Kouraklis, Stamatios Theocharis. Histone deacetylase (HDAC)-1, −2, −4 and −6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients’ survival. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0379-y
|
| 14 |
Masumeh Sanaei, Fraidoon Kavoosi. Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers. Advanced Biomedical Research 2019; 8(1): 63 doi: 10.4103/abr.abr_142_19
|
| 15 |
Xue-Song Xiang, Peng-Cheng Li, Wen-Quan Wang, Liang Liu. Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(1): 188676 doi: 10.1016/j.bbcan.2022.188676
|
| 16 |
Min Kyu Jung. Nutritional Support for Patients with Pancreatic Cancer. The Korean Journal of Gastroenterology 2019; 74(2): 87 doi: 10.4166/kjg.2019.74.2.87
|
| 17 |
Nabil A. Alhakamy, Shaimaa M. Badr-Eldin, Waleed S. Alharbi, Mohamed A. Alfaleh, Omar D. Al-hejaili, Hibah M. Aldawsari, Basma G. Eid, Rana Bakhaidar, Filippo Drago, Filippo Caraci, Giuseppe Caruso. Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells. Pharmaceuticals 2021; 14(12): 1309 doi: 10.3390/ph14121309
|
| 18 |
Dharmalingam Subramaniam, Ravi Thombre, Animesh Dhar, Shrikant Anant. DNA Methyltransferases: A Novel Target for Prevention and Therapy. Frontiers in Oncology 2014; 4 doi: 10.3389/fonc.2014.00080
|
| 19 |
Arshad Ali, Ayaz Ali, Hema S. Devi, Jayasimha R. Daddam, Rabiah Sarwar, Farheen Khan Badrealam. The HDAC2/YY1/c‐Myc signaling axis regulates lung cancer cell migration and proliferation. Environmental Toxicology 2023; 38(8): 1989 doi: 10.1002/tox.23825
|
| 20 |
Kazuya Shimizu, Takaaki Nishiyama, Yuichi Hori. Gemcitabine Enhances Kras-MEK–Induced Matrix Metalloproteinase-10 Expression Via Histone Acetylation in Gemcitabine-Resistant Pancreatic Tumor-initiating Cells. Pancreas 2017; 46(2): 268 doi: 10.1097/MPA.0000000000000744
|
| 21 |
Xu Han, Tiantao Kuang, Yun Ren, Zhufeng Lu, Qingwu Liao, Wei Chen. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo. Experimental Cell Research 2019; 385(1): 111605 doi: 10.1016/j.yexcr.2019.111605
|
| 22 |
Shahrzad Movafagh, Amanda Munson. Epigenetics of Cancer Prevention. 2019; : 75 doi: 10.1016/B978-0-12-812494-9.00004-4
|
| 23 |
Bing Wang, Xin-bao Wang, Li-yu Chen, Ling Huang, Rui-zen Dong. Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis. Biochemical and Biophysical Research Communications 2013; 437(1): 1 doi: 10.1016/j.bbrc.2013.05.090
|
| 24 |
Kwai Fung Hui, Alan K.S. Chiang. Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism. International Journal of Cancer 2014; 135(12): 2950 doi: 10.1002/ijc.28924
|
| 25 |
Sally E. Henderson, Neil Makhijani, Thomas A. Mace. Pancreatic Cancer–Induced Cachexia and Relevant Mouse Models. Pancreas 2018; 47(8): 937 doi: 10.1097/MPA.0000000000001124
|
| 26 |
Marzieh Ramezani Farani, Maryam Sarlak, Amir Gholami, Maryam Azaraian, Maryam Moradi Binabaj, Sareh Kakavandi, Murtaza M. Tambuwala, Afshin Taheriazam, Mehrdad Hashemi, Sorayya Ghasemi. Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?. Pathology - Research and Practice 2023; 248: 154688 doi: 10.1016/j.prp.2023.154688
|
| 27 |
Andrew E. Shouksmith, Fenil Shah, Michelle L. Grimard, Justyna M. Gawel, Yasir S. Raouf, Mulu Geletu, Angelika Berger-Becvar, Elvin D. de Araujo, H. Artee Luchman, William L. Heaton, David Bakhshinyan, Ashley A. Adile, Chitra Venugopal, Thomas O’Hare, Michael W. Deininger, Sheila K. Singh, Stephen F. Konieczny, Samuel Weiss, Melissa L. Fishel, Patrick T. Gunning. Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer. Journal of Medicinal Chemistry 2019; 62(5): 2651 doi: 10.1021/acs.jmedchem.8b01957
|
| 28 |
Hanieh Jafary, Shahin Ahmadian, Masoud Soleimani. The enhanced apoptosis and antiproliferative response to combined treatment with valproate and nicotinamide in MCF-7 breast cancer cells. Tumor Biology 2014; 35(3): 2701 doi: 10.1007/s13277-013-1356-0
|
| 29 |
Yusuke Kojima, Reeja S. Maskey, Yuichi J. Machida. Pancreatic Cancer. 2018; : 19 doi: 10.1007/978-1-4939-7193-0_74
|
| 30 |
Deepkamal N. Karelia, Sangyub Kim, Manoj K. Pandey, Daniel Plano, Shantu Amin, Junxuan Lu, Arun K. Sharma. Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity. International Journal of Molecular Sciences 2021; 22(9): 4966 doi: 10.3390/ijms22094966
|
| 31 |
Ammar Abdul Aziz Alibeg, Mohammed Hassan Mohammed. Design, synthesis, insilco study and biological evaluation of new isatin-sulfonamide derivatives by using mono amide linker as possible as histone deacetylase inhibitors. Polski Merkuriusz Lekarski 2024; 52(2): 178 doi: 10.36740/Merkur202402106
|
| 32 |
Immacolata Maietta, Amparo Martínez-Pérez, Rosana Álvarez, Ángel R. De Lera, África González-Fernández, Rosana Simón-Vázquez. Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells. Pharmaceuticals 2022; 15(7): 824 doi: 10.3390/ph15070824
|
| 33 |
Ronald-Allan Panganiban, Andrew Snow, Regina Day. Mechanisms of Radiation Toxicity in Transformed and Non-Transformed Cells. International Journal of Molecular Sciences 2013; 14(8): 15931 doi: 10.3390/ijms140815931
|
| 34 |
Sally E. Henderson, Li-Yun Ding, Xiaokui Mo, Tanios Bekaii-Saab, Samuel K. Kulp, Ching-Shih Chen, Po-Hsien Huang. Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42. Neoplasia 2016; 18(12): 765 doi: 10.1016/j.neo.2016.10.003
|
| 35 |
Andee Weisbeck, Rick Jansen. Nutrients and the Pancreas: An Epigenetic Perspective. Nutrients 2017; 9(3): 283 doi: 10.3390/nu9030283
|